2021 Scientific Sessions

Abstract Session E: Intervention for Stable Ischemic Heart Disease

Outcomes with Drug-coated balloons vs. Drug-eluting Stents in Small-Vessel Coronary Artery Disease
Michael S Megaly, M.D., FSCAI, Henry Ford Hospital, Bossier City, LA, Kevin G Buda, MD, Hennepin Healthcare, Minneapolis, MN, Marwan Saad, M.D., Ph.D., FSCAI, Brown University, Providence, RI, Mariam Tawadros, MD, Ain Shams University Faculty of Medicine, Cairdo, Egypt, Ayman Elbadawi, MD, The University of Texas Medical Branch, Galveston, TX, Babar B Basir, DO, FSCAI, Henry Ford Health System, Detroit, MI, J. Dawn Abbott, M.D., FSCAI, Rhode Island Hospital, Barrington, RI, Stéphane Rinfret, M.D., FSCAI, Georgia Heart Institute, Atlanta, GA, Khaldoon Alaswad, M.D., FSCAI, Henry Ford Hospital, Detroit, MI and Emmanouil S. Brilakis, MD, PhD, FSCAI, Minneapolis Heart Institute® - Abbott Northwestern Hospital, Minneapolis, MN
Sex-based outcomes after PCI in high-bleeding risk patients: Results from the Onyx ONE Clear trial
Roxana Mehran, M.D., MSCAI1, David E. Kandzari, M.D., FSCAI2, Ajay J. Kirtane, M.D., FSCAI3, Matthew J. Price, MD4, Daniel I. Simon, M.D.5, Azeem Latib, M.D., FSCAI6, Elvin Kedhi, MD, PhD7, Alexandre Abizaid, M.D.8, Azfar Zaman, MD9, Maria Parke10, Te-Hsin Lung10, Stephan Windecker, M.D.11 and Gregg W. Stone, M.D.12, (1)Icahn School of Medicine at Mount Sinai, New York, NY, (2)Piedmont Heart Institute, Atlanta, GA, (3)NewYork-Presbyterian Columbia University Irving Medical Center, New York, NY, (4)Scripps Clinic Medical Group, La Jolla, CA, (5)University Hospitals Cleveland Medical Center, Cleveland, OH, (6)Montefiore Medical Center, Bronx, NY, (7)Université Libre de Brussels, Brussels, Belgium, (8)Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil, (9)Freeman Hospital and Newcastle University, Newcastle upon Tyne, United Kingdom, (10)Medtronic, Santa Rosa, CA, (11)The University of Bern, Bern, Switzerland, (12)Icahn School of Medicine at Mount Sinai, New York City, NY
Revascularization Very Elderly Patients with Left Ventricular Dysfunction and Stable Ischemic Heart Disease
Derek Q. Phan, M.D.1, Jesse Goitia, M.D.1, Ming-Sum Lee, M.D., PhD1, Brendan Kim, M.D.1, Naing A. Moore, M.D.2, Prakash W. Mansukhani, M.D.3, Vicken J. Aharonian, M.D., FSCAI3, Somjot S. Brar, M.D., FSCAI1 and Ray Zadegan, M.D.1, (1)Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, (2)-, South Pasadena, CA, (3)Kaiser Permanente, Los Angeles, CA
Revascularization Versus Medical Therapy in Very Elderly Patients with Baseline Renal Dysfunction for Stable Ischemic Heart Disease
Derek Q. Phan, M.D.1, Jesse Goitia, M.D.1, Ming-Sum Lee, M.D., PhD1, Brendan Kim, M.D.1, Naing A. Moore, M.D.2, Prakash W. Mansukhani, M.D.3, Vicken J. Aharonian, M.D., FSCAI3, Somjot S. Brar, M.D., FSCAI1 and Ray Zadegan, M.D.1, (1)Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, (2)-, South Pasadena, CA, (3)Kaiser Permanente, Los Angeles, CA
Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting Versus Medical Therapy in Very Elderly Diabetic Patients With Stable Ischemic Heart Disease
Derek Q. Phan, M.D.1, Jesse Goitia, M.D.1, Ming-Sum Lee, M.D., PhD1, Brendan Kim, M.D.1, Naing A. Moore, M.D.2, Prakash W. Mansukhani, M.D.3, Vicken J. Aharonian, M.D., FSCAI3, Somjot S. Brar, M.D., FSCAI1 and Ray Zadegan, M.D.1, (1)Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, (2)-, South Pasadena, CA, (3)Kaiser Permanente, Los Angeles, CA
Prognostic utility of coronary angiography in pre-operative cardiac evaluation for liver transplantation
Anoshia Raza, MD, FSCAI1, Phillip Lim, MD2, Maciej Tysarowski, MD2, John Bertot, BS2, Paul Ippolito, BS2, Christine Gerula3, Alfonso Waller, MD2, Julius Gardin, MD, MBA2 and Marc Klapholz, MD, MBA, FSCAI2, (1)Rutgers New Jersey Medical School, Bloomfield, NJ, (2)Rutgers New Jersey Medical School, Newark, NJ, (3)Christine Marie Gerula, MD, Newark, NJ
See more of: Coronary